Literature DB >> 12228782

How long is too long? Association of time delay to successful reperfusion and ventricular function outcome in acute myocardial infarction: the case for thrombolytic therapy before planned angioplasty for acute myocardial infarction.

Conor F Lundergan1, Jonathan S Reiner, Allan M Ross.   

Abstract

OBJECTIVES: The purpose of this study was to quantify the effect of time delays to reperfusion on ventricular function after myocardial infarction. This allows one to identify a group of patients in whom a strategy using antecedent pharmacologic reperfusion therapy before planned direct angioplasty may offer significant benefit.
BACKGROUND: Direct angioplasty for myocardial infarction is associated with a high rate of successful reperfusion compared with pharmacologic reperfusion. However, there is an inherent time delay to treatment with angioplasty compared with pharmacologic therapy. There currently are insufficient data to determine the consequences of incremental time delays to reperfusion on ventricular function.
METHODS: We determined, by logistic regression analysis, the probability of observing a decrement in postmyocardial infarction ventricular function as a function of incremental time delays to reperfusion.
RESULTS: Time delays of 30, 60, 90, or 120 minutes to reperfusion increased the likelihood of a worse ventricular function outcome by 1.1-, 1.3-, 1.5-, and 1.7-fold, respectively (P <.02). The upper 95% confidence limits around these odds ratios are as high as 1.3 or 2.7 for 30- and 120-minute delays, respectively. Time from symptom onset to patency remained a significant determinant of ventricular function after adjustment for clinical and procedural factors.
CONCLUSIONS: Delay in time to reperfusion, measured in minutes, results in significant loss of ventricular function after myocardial infarction. Interventional strategies designed for treatment of myocardial infarction when "door-to-balloon" time is expected to exceed 60 minutes should strongly consider incorporation of pharmacologic reperfusion therapy into the therapeutic paradigm.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228782     DOI: 10.1067/mhj.2002.124868

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

Review 1.  A review of interventions and system changes to improve time to reperfusion for ST-segment elevation myocardial infarction.

Authors:  Kelly A McDermott; Christian D Helfrich; Anne E Sales; John S Rumsfeld; P Michael Ho; Stephan D Fihn
Journal:  J Gen Intern Med       Date:  2008-05-06       Impact factor: 5.128

2.  Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study.

Authors:  Thao Huynh; Jennifer O'Loughlin; Lawrence Joseph; Erick Schampaert; Stéphane Rinfret; Marc Afilalo; Simon Kouz; Bernard Cantin; Michel Nguyen; Mark J Eisenberg
Journal:  CMAJ       Date:  2006-12-05       Impact factor: 8.262

3.  Symptom-to-door time in ST segment elevation myocardial infarction: overemphasized or overlooked? Results from the AMI-McGill study.

Authors:  Jonathan Afilalo; Nicolo Piazza; Sonia Tremblay; Nathalie Soucy; Thao Huynh
Journal:  Can J Cardiol       Date:  2008-03       Impact factor: 5.223

4.  Association between time to emergency neurosurgery and clinical outcomes for spontaneous hemorrhagic stroke: A nationwide observational study.

Authors:  Ki Hong Kim; Young Sun Ro; Jeong Ho Park; Joo Jeong; Sang Do Shin; Sungwoo Moon
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.240

5.  Longitudinal peak strain detects a smaller risk area than visual assessment of wall motion in acute myocardial infarction.

Authors:  Lene Rosendahl; Peter Blomstrand; Lars Brudin; Tim Tödt; Jan E Engvall
Journal:  Cardiovasc Ultrasound       Date:  2010-01-11       Impact factor: 2.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.